跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MICAFUNGIN FOR INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MICAFUNGIN FOR INJECTION, USP
Authorized
STANDARD
MICAFUNGIN FOR INJECTION, USP
BIOCON PHARMA LIMITED
🇨🇦 Health Canada
Approval Date
Aug 7, 2026
Approval ID
a35b2bcb3f859df1
Company
BIOCON PHARMA LIMITED
Type
Standard
Approval Details
Approval Id
a35b2bcb3f859df1
Drug Approval Canada Name
MICAFUNGIN FOR INJECTION, USP
Product Name
MICAFUNGIN FOR INJECTION, USP
Status
Approved
Status Date
2026-05-08
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
PRESCRIPTION
Atc Original
J02AX05 MICAFUNGIN
Aig Number
0152203003
Company Name
BIOCON PHARMA LIMITED
Company Address
20th Km, Hosur Road, Electronics City Bengaluru Karnataka India 560100
Company Detail Path
/organization/biocon-pharma-limited
Company Information
Pharmaceutical Company Name
BIOCON PHARMA LIMITED
Country Name
India
Province Name
Karnataka
City Name
bengaluru,karnataka,country_in
Address
Special Economic Zone, Block F1, Plot No.5, Phase IV,
Active Ingredients
MICAFUNGIN SODIUM
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Aug 7, 2026
Approval ID
a35b2bcb3f859df1
Type
Standard
Back to Health Canada Approvals